An infant botulism outbreak has sickened at least 39 babies across the U.S. and underscored the crucial role of a medication ...

Convalescent plasma does not reduce the risk of intubation or death in COVID-19 patients, according to a study which found that people receiving the therapy experienced more serious adverse events ...

Last month, The US Food and Drug Administration approved a new blood test for assisting the diagnosis of Alzheimer’s disease. Produced by Roche, Elecsys pTau181 measures the concentration of a ...

Sept 19 (Reuters) - Regeneron (REGN.O), opens new tab said on Friday its experimental therapy showed either a complete or partial disappearance of a precancerous disorder, which manifests into blood ...

Aldosterone dysregulation plays an important pathogenic role in hard-to-control hypertension. In several studies, baxdrostat, an aldosterone synthase inhibitor, reduced the seated systolic blood ...

SAVANNAH, Ga. (WTOC) - Running is in Lovelight Burns’ blood. And her blood has helped her get back to running. Burns pursued an alternative when 40 years of training for marathons compromised her ...

Velico recently completed its first-in-human Phase I multi-center clinical trial of FrontlineODP™ Spray Dried Plasma in healthy volunteers. The dose-escalation study with a randomized, crossover ...

The treatment uses a patient’s blood to support tissue regeneration, reduce inflammation, and improve mobility. A platelet-rich plasma system known as Endoret PRGF (plasma rich in growth factors) is ...

Treatment with platelet-rich plasma provided statistically significant long-lasting relief of chronic noncancer pain that was superior to results with corticosteroid and hyaluronic acid injections.